LifeStance Health Group, Inc.
LFST
$6.50
-$0.06-0.92%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 5.36% | 3.71% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 5.36% | 3.71% | |||
| Cost of Revenue | 4.37% | 6.14% | |||
| Gross Profit | 7.52% | -1.24% | |||
| SG&A Expenses | -1.73% | 3.12% | |||
| Depreciation & Amortization | -3.21% | 1.82% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.36% | 5.10% | |||
| Operating Income | 348.61% | -283.92% | |||
| Income Before Tax | 176.94% | -304.22% | |||
| Income Tax Expenses | 262.48% | 1.28% | |||
| Earnings from Continuing Operations | 128.41% | -634.70% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 128.41% | -634.70% | |||
| EBIT | 348.61% | -283.92% | |||
| EBITDA | 88.96% | -28.02% | |||
| EPS Basic | 128.57% | -644.44% | |||
| Normalized Basic EPS | 176.04% | -300.00% | |||
| EPS Diluted | 128.00% | -655.56% | |||
| Normalized Diluted EPS | 175.00% | -300.00% | |||
| Average Basic Shares Outstanding | 0.06% | 0.90% | |||
| Average Diluted Shares Outstanding | 0.56% | -1.01% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||